Fecal microbiota transplantation in relapsing Clostridium difficile infection

Therapeutic Advances in Gastroenterology

Volumn 5, Issue 6, 2012, Pages 403-420

  Rohlke, Faith ^a   Stollman, Neil ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Northern California Gastroenterology Associates   (United States)

Author keywords

Clostridium difficile; Fecal bacteriotherapy; Fecal flora; Fecal flora reconstitution; Fecal microbiota transplantation; Fecal transplant; Recurrent Clostridium difficile infection; Stool transplantation

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; LOPERAMIDE; METRONIDAZOLE; OMEPRAZOLE; PROBIOTIC AGENT; VANCOMYCIN;

BACTERIAL VIRULENCE; BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DONOR; DRUG WITHDRAWAL; EDEMA; FECAL MICROBIOTA TRANSPLANTATION; FECES; FECES MICROFLORA; HUMAN; PRIORITY JOURNAL; REVIEW; SCREENING TEST; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 84868254408     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X12453637     Document Type: Review

References (85)

1. Aas J. Gessert C. Bakken J. (2003) Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36: 580–585.
2. Ananthakrishnan A. (2011) Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 8: 17–26.
3. Ananthakrishnan A. Issa M. Binion D. (2009) Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am 38: 711–728.
4. Arkkila P. Uusitalo-Seppala R. Lehtola L. Moilanen V. Ristikankare M. Mattila E. (2010) 29 Fecal Bacteriotherapy for Recurrent Clostridium Difficile Infection. Philadelphia, PA: W.B. Saunders.
5. Aslam S. Hamill R. Musher D. (2005) Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 5: 549–557.
6. Bakken J. (2009) Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15: 285–289.
7. Bakken J. Borody T. Brandt L. Brill J. Demarco D. Franzos M. et al. (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9: 1044–1049.
8. Bartlett J. (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346: 334–339.
9. Bauer M. Notermans D. van Benthem B. Brazier J. Wilcox M. Rupnik M. et al. (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377: 63–73.
10. Bennet J. Brinkman M. (1989) Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1: 164.
11. Borody T. (2000) ‘Flora Power’– fecal bacteria cure chronic C. difficile diarrhea. Am J Gastroenterol 95: 3028–3029.
12. Borody T. Khoruts A. (2011) Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9: 86–96.
13. Borody T. Leis S. Pang G. Borody T. (2012) Fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection. In: Ed. Basow D. (ed.), Up To Date. Waltham, MA.
14. Borody T. Warren E. Leis S. Surace R. Ashman O. (2003) Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37: 42–47.
15. Borody T. Warren E. Leis S. Surace R. Ashman O. Siarakas S. (2004) Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 38: 475–483.
16. Borody T. Wettstein A. Leis S. Hills L. Campbell J. Torres M. (2001) Clostridium difficile complicating inflammatory bowel diseases: pre- and post-treatment findings. Gastroenterol 134(4 Suppl 1): A-361.
17. Bowden T. Jr Mansberger A. Jr Lykins L. (1981) Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 47: 178–183.
18. Brandt L. Aroniadis O. Mellow M. Kanatzar A. Kelly C. Park T. et al. (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. [Epub ahead of print]. Doi: 10.1038/ajg.2012.60.
19. Brandt L. Reddy S. (2011) Fecal microbiota transplantation for recurrent Clostridium difficile infection. J Clin Gastroenterol 45(Suppl): S159–S167.
20. CDC, (2005) Severe Clostridium difficile-associated disease in populations previously at low risk – four states, 2005. MMWR Morb Mortal Wkly Rep 54: 1201–1205.
21. Cohen S. Gerding D. Johnson S. Kelly C. Loo V. McDonald L. et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31: 431–455.
22. Duplessis C. You D. Johnson M. Speziale A. (2011) Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection. Infection. [Epub ahead of print]
23. Eggertson L. (2004) C. difficile: by the numbers. CMAJ 171: 1331–1332.
24. Eiseman B. Silen W. Bascom G. Kauvar A. (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44: 854–859.
25. Fenton S. Stephenson D. Weder C. (1974) Pseudomembranous colitis associated with antibiotic therapy – an emerging entity. CMAJ 111: 1110–1111.
26. Festi D. Schiumerini R. Birtolo C. Marzi L. Montrone L. Scaioli E. et al. (2011) Gut microbiota and its pathophysiology in disease paradigms. Dig Dis 29: 518–524.
27. Garborg K. Waagsbo B. Stallemo A. Matre J. Sundoy A. (2010) Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 42: 857–861.
28. Girotra M. Bartlett J. Koerner K. Dutta S. (2011) Combined jejunal and colonic fecal bacteriotherapy in patients with recurrent Clostridium difficile infection (RCDI). Am J Gastroenterol.
29. Ghoshal U. Shukla R. Ghoshal U. Gwee K. Ng S. Quigley E. (2012) The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam 151085.
30. Gough E. Shaikh H. Manges A. (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53: 994–1002.
31. Grehan M. Borody T. Leis S. Campbell J. Mitchell H. Wettstein A. (2010) Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 44: 551–561.
32. Guo B. Harstall C. Louie T. Veldhuyzen van Zanten S. Dieleman L. (2012) Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 35: 865–875.
33. Gustafsson A. Berstad A. Lund-Tonnesen S. Midtvedt T. Norin E. (1999) The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 34: 580–586.
34. Gustafsson A. Lund-Tonnesen S. Berstad A. Midtvedt T. Norin E. (1998) Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 33: 721–727.
35. Hamilton M. Weingarden A. Sadowsky M. Khoruts A. (2012) Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107 (5): 761–767.
36. Harrell L. Wang Y. Antonopoulos D. Young V. Lichtenstein L. Huang Y. et al. (2012) Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PloS ONE 7: e32545.
37. Heinlen L. Ballard J. (2010) Clostridium difficile infection. Am J Med Sci 340: 247–252.
38. Hellemans R. Naegels S. Holvoet J. (2009) Fecal transplantation for recurrent Clostridium difficile colitis, an underused treatment modality. Acta Gastroenterol Belg 72: 269–270.
39. Ho N. Prasad V. (2011) Clostridium difficile diarrhea and fecal transplantation. J Clin Gastroenterol 45: 742–743.
40. Hookman P. Barkin J. (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15: 1554–1580.
41. Johnson S. (2009) Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 58: 403–410.
42. Jorup-Ronstrom C. Hakanson A. Persson A. Midtvedt T. Norin E. (2006) Feces culture successful therapy in Clostridium difficile diarrhea. Lakartidningen 103: 3603–3605.
43. Kassam Z. Hundal R. Marshall J. Lee C. (2012) Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 172: 191–193.
44. Kelly C. de Leon L. Jasutkar N. (2012) Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 46: 145–149.
45. Khoruts A. Dicksved J. Jansson J. Sadowsky M. (2010) Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44: 354–360.
46. Kyne L. Sougioultzis S. McFarland L. Kelly C. (2002) Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23: 653–659.
47. Landy J. Al-Hassi H. McLaughlin S. Walker A. Ciclitira P. Nicholls R. et al. (2011) Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Thera 34: 409–415.
48. Lee Y. Wang J. Chen A. Sheng W. Chang S. Chen Y. (2011) Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan. J Microbiol Immunol Infect. [Epub ahead of print]
49. Loo V. Poirier L. Miller M. Oughton M. Libman M. Michaud S. et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. New Engl J Med 353: 2442–2449.
50. Louie T. (2008) Home-based Fecal Flora Infusion to Arrest Multiply-recurrend Clostridium difficile infection (CDI). Arlington, VA: Infectious Disease Society of America.
51. Lund-Tonnesen S. Berstad A. Schreiner A. Midtvedt T. (1998) Clostridium difficile-associated diarrhea treated with homologous feces. Tidsskr Nor Laegeforen 118: 1027–1030.
52. Maccaferri S. Biagi E. Brigidi P. (2011) Metagenomics: key to human gut microbiota. Dig Dis 29: 525–530.
53. MacConnachie A. Fox R. Kennedy D. Seaton R. (2009) Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 102: 781–784.
54. Mattila E. Uusitalo-Seppala R. Wuorela M. Lehtola L. Nurmi H. Ristikankare M. et al. (2012) Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection Gastroenterology 142 (3): 490–6.
55. McDonald L. Killgore G. Thompson A. Owens R. Jr Kazakova S. Sambol S. et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. New Engl J Med 353: 2433–2441.
56. McDonald L. Owings M. Jernigan D. (2006) Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 12: 409–415.
57. McFarland L. (1998) Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 16: 292–307.
58. McFarland L. (2009) Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies. Curr Opin Gastroenterol 25: 24–35.
59. McFarland L. Elmer G. Surawicz C. (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97: 1769–1775.
60. McFarland L. Surawicz C. Rubin M. Fekety R. Elmer G. Greenberg R. (1999) Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 20: 43–50.
61. Mellow M. Kanatzar A. (2011) Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection – results and follow-up. J Okla State Med Assoc 104 (3): 89–91.
62. Mellow M. Kanatzar A. Brandt L. Aroniadis O. Kelly C. Park T. et al. (2011) Longterm follow-up of colonoscopic fecal microbiota transplant (FMT) for recurrent C. difficile infection (RCDI). Am J Gastroenterol 106 (Suppl 2): S149–S150.
63. Musgrave C. Bookstaver P. Sutton S. Miller A. (2011) Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection. Int J Infect Dis 15: e438–e448.
64. Nieuwdorp M. van Nood E. Speelman P. van Heukelem H. Jansen J. Visser C. et al. (2008) Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces. Ned Tijdschr Geneeskd 152: 1927–1932.
65. Paterson D. Iredell J. Whitby M. (1994) Putting back the bugs: bacterial treatment relieves chronic diarrhoea. Med J Aust 160: 232–233.
66. Pepin J. Alary M. Valiquette L. Raiche E. Ruel J. Fulop K. et al. (2005 a) Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40: 1591–1597.
67. Pepin J. Saheb N. Coulombe M. Alary M. Corriveau M. Authier S. et al. (2005 b) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41: 1254–1260.
68. Persky S. Brandt L. (2000) Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 95: 3283–3285.
69. Rohlke F. Surawicz C. Stollman N. (2010) Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 44: 567–570.
70. Rubin T. Gessert C. Aas J. (2009) Stool transplantation for older patients with Clostridium difficile infection. J Am Geriatr Soc 57: 2386.
71. Rupnik M. Wilcox M. Gerding D. (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7: 526–536.
72. Russell G. Kaplan J. Ferraro M. Michelow I. (2010) Fecal bacteriotherapy for relapsing Clostridium difficile infection in a child: a proposed treatment protocol. Pediatrics 126: e239–e242.
73. Sage R. Rao D. Burke R. Lim H. (2011) Preventing vitamin D toxicity in patients with sarcoidosis. J Am Acad Dermatol 64: 795–796.
74. Schwan A. Sjolin S. Trottestam U. Aronsson B. (1983) Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 2: 845.
75. Schwan A. Sjolin S. Trottestam U. Aronsson B. (1984) Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 16: 211–215.
76. Shin B. Kuak E. Yoo H. Kim E. Lee K. Kang J. et al. (2008) Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: esults of a retrospective study 2000–2005. J Med Microbiol 57: 697–701.
77. Silverman M. Davis I. Pillai D. (2010) Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 8: 471–473.
78. Sofi A. Nawras A. Sodeman T. Garborg K. Silverman A. (2011) Fecal bacteriotherapy works for Clostridium difficile infection – a meta-analysis. Am J Gastroenterol.
79. Tvede M. Rask-Madsen J. (1989) Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1: 1156–1160.
80. van Nood E. Speelman P. Kuijper E. Keller J. (2009) Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill 14: 19316.
81. Warny M. Pepin J. Fang A. Killgore G. Thompson A. Brazier J. et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079–1084.
82. Wettstein A. Borody T. Leis S. Chongan J. Torres M. Hills L. (2007) Faecal bacteriotherapy – an effective treatment for relapsing symptomatic Clostridium difficile infection. Abstract WED-G-67. In: 15th Gut. United European Gastroenterology Week (France) 39(Suppl 1): A303. Vienna: United European Gastroenterology Federation.
83. Yoon S. Brandt L. (2010) Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol 44: 562–566.
84. You D. Franzos M. Holman R. (2008) Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy. Ann Intern Med 148: 632–633.
85. Zar F. Bakkanagari S. Moorthi K. Davis M. (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45: 302–307.